ALT5 Sigma to Exhibit at iFX EXPO Dubai January 14-16, 2025
ALT5 Sigma (NASDAQ:ALTS) has announced its participation in the upcoming iFX EXPO Dubai at the Dubai World Trade Centre from January 14-16, 2025. The company will showcase at booth #26, offering product demonstrations and solutions to over 7,000 expected attendees.
ALT5 Sigma, a fintech company listed on Nasdaq and part of the Russell Microcap Index, provides blockchain-powered technologies for digital assets. Through its subsidiary ALT5 Sigma Inc., the company operates two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform. The company processed over US$1.2 billion in cryptocurrency transactions in 2023.
The company also maintains biotech activities focused on developing solutions to address the opioid crisis, with drugs in clinical trials targeting pain management alternatives to addictive opioids.
ALT5 Sigma (NASDAQ:ALTS) ha annunciato la sua partecipazione al prossimo iFX EXPO Dubai che si svolgerà al Dubai World Trade Centre dal 14 al 16 gennaio 2025. L'azienda esporrà allo stand #26, offrendo dimostrazioni di prodotto e soluzioni per oltre 7.000 partecipanti previsti.
ALT5 Sigma, una compagnia fintech quotata al Nasdaq e parte dell'indice Russell Microcap, fornisce tecnologie basate su blockchain per asset digitali. Attraverso la sua sussidiaria ALT5 Sigma Inc., l'azienda opera due piattaforme principali: ALT5 Pay, una gateway di pagamento in criptovalute, e ALT5 Prime, una piattaforma elettronica di trading over-the-counter. L'azienda ha elaborato oltre 1,2 miliardi di dollari USA in transazioni in criptovaluta nel 2023.
L'azienda mantiene anche attività nel settore biotech focalizzate sullo sviluppo di soluzioni per affrontare la crisi degli oppioidi, con farmaci in sperimentazione clinica mirati a offrire alternative per la gestione del dolore rispetto agli oppioidi tossicodipendenti.
ALT5 Sigma (NASDAQ:ALTS) ha anunciado su participación en el próximo iFX EXPO Dubai que tendrá lugar en el Dubai World Trade Centre del 14 al 16 de enero de 2025. La empresa se exhibirá en el stand #26, ofreciendo demostraciones de productos y soluciones a más de 7,000 asistentes previstos.
ALT5 Sigma, una empresa fintech que cotiza en Nasdaq y forma parte del índice Russell Microcap, proporciona tecnologías impulsadas por blockchain para activos digitales. A través de su filial ALT5 Sigma Inc., la compañía opera dos plataformas principales: ALT5 Pay, una pasarela de pago de criptomonedas, y ALT5 Prime, una plataforma de negociación electrónica extrabursátil. La empresa procesó más de 1.2 mil millones de dólares estadounidenses en transacciones de criptomonedas en 2023.
La empresa también mantiene actividades en biotecnología centradas en el desarrollo de soluciones para abordar la crisis de los opioides, con medicamentos en ensayos clínicos dirigidos a proporcionar alternativas a los opioides adictivos para el manejo del dolor.
ALT5 Sigma (NASDAQ:ALTS)는 2025년 1월 14일부터 16일까지 두바이 월드 트레이드 센터에서 열리는 iFX EXPO Dubai에 참가한다고 발표했습니다. 회사는 부스 #26에서 제품 시연 및 해결책을 제공할 예정이며, 예상 참석자는 7,000명이 넘습니다.
ALT5 Sigma는 나스닥에 상장되어 있으며 러셀 마이크로캡 지수의 일원인 핀테크 회사로, 디지털 자산을 위한 블록체인 기반 기술을 제공합니다. ALT5 Sigma Inc.라는 자회사를 통해 회사는 두 개의 주요 플랫폼을 운영하고 있습니다: ALT5 Pay, 암호화폐 결제 게이트웨이, 그리고 ALT5 Prime, 전자 장외 거래 플랫폼입니다. 이 회사는 2023년 동안 암호화폐 거래에서 12억 달러 이상의 거래를 처리했습니다.
회사는 또한 중독성 오피오이드에 대한 대안으로서 통증 관리 솔루션을 개발하기 위한 임상 시험 중인 약물을 포함하여, 오피오이드 위기를 해결하기 위한 생명공학 활동도 유지하고 있습니다.
ALT5 Sigma (NASDAQ:ALTS) a annoncé sa participation au prochain iFX EXPO Dubai qui se tiendra au Dubai World Trade Centre du 14 au 16 janvier 2025. L'entreprise sera présente au stand #26, offrant des démonstrations de produits et des solutions à plus de 7 000 participants attendus.
ALT5 Sigma, une entreprise fintech cotée sur le Nasdaq et faisant partie de l'indice Russell Microcap, fournit des technologies basées sur la blockchain pour les actifs numériques. À travers sa filiale ALT5 Sigma Inc., la société exploite deux plateformes principales : ALT5 Pay, une passerelle de paiement en cryptomonnaie, et ALT5 Prime, une plateforme de trading électronique de gré à gré. L'entreprise a traité plus de 1,2 milliard de dollars américains en transactions de cryptomonnaies en 2023.
La société maintient également des activités biopharmaceutiques axées sur le développement de solutions pour faire face à la crise des opioïdes, avec des médicaments en essais cliniques visant à offrir des alternatives à la gestion de la douleur par rapport aux opioïdes addictifs.
ALT5 Sigma (NASDAQ:ALTS) hat seine Teilnahme an der bevorstehenden iFX EXPO Dubai angekündigt, die vom 14. bis 16. Januar 2025 im Dubai World Trade Centre stattfinden wird. Das Unternehmen wird am Stand #26 ausstellen und Produktdemonstrationen sowie Lösungen für über 7.000 erwartete Teilnehmer anbieten.
ALT5 Sigma, ein an der Nasdaq notiertes Fintech-Unternehmen und Teil des Russell Microcap Index, bietet blockchain-basierte Technologien für digitale Vermögenswerte an. Über seine Tochtergesellschaft ALT5 Sigma Inc. betreibt das Unternehmen zwei Hauptplattformen: ALT5 Pay, ein Kryptowährungs-Zahlungsgateway, und ALT5 Prime, eine elektronische Over-the-Counter-Handelsplattform. Das Unternehmen hat im Jahr 2023 über 1,2 Milliarden US-Dollar an Kryptowährungstransaktionen verarbeitet.
Das Unternehmen unterhält auch biotechnologische Aktivitäten, die sich auf die Entwicklung von Lösungen zur Bekämpfung der Opioidkrise konzentrieren, wobei Medikamente in klinischen Studien entwickelt werden, die auf Schmerzmanagement-Alternativen zu suchtgefährdenden Opioiden abzielen.
- Processed over US$1.2 billion in cryptocurrency transactions in 2023
- Part of Russell Microcap Index
- Operates two established platforms: ALT5 Pay and ALT5 Prime
- None.
LAS VEGAS, NV / ACCESSWIRE / January 9, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, announced its participation in the upcoming iFX EXPO Dubai.
ALT5 will be exhibiting through the three days of the show at the Dubai World Trade Centre, providing product demonstrations, solutions and general information to many of the 7,000+ attendees starting January 14th in booth #26.
iFX EXPO Dubai 2025 is the ultimate meeting place for brokers, affiliates, traders, investors, and tech- and service-providers who are looking to succeed in the MENA region.
"ALT5 continues to showcase at iFX tradeshows around the world because it is a very significant and important industry segment. By listening to and engaging with new and existing clients at iFX Dubai, ALT5 remains on the leading edge of innovation and technology. We finished 2024 with strong business momentum and look to continue that into the new year." said Vay Tham, CRO ALT5 Sigma Corporation.
About ALT5 Sigma
The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.
Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US
ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.
Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Contact Information
Investor Relations
ir@alt5sigma.com
1-800-400-2247
SOURCE: ALT5 Sigma Corp
View the original press release on accesswire.com
FAQ
How much in cryptocurrency transactions did ALT5 Sigma (ALTS) process in 2023?
When and where is ALT5 Sigma (ALTS) exhibiting at iFX EXPO Dubai 2025?
What are the main platforms offered by ALT5 Sigma (ALTS)?
When was ALT5 Sigma (ALTS) included in the Russell Microcap Index?
What payment options does ALT5 Pay (ALTS) offer to merchants?
